Stay updated on Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial
Sign up to get notified when there's something new on the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page.

Latest updates to the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page
- Check5 days agoChange DetectedA new revision entry (v3.5.5) was added to the study record history, updating the version history to reflect the latest revision. This change updates the historical log rather than the actual study data or visible content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe Record History adds the latest revision v3.5.4, replacing v3.5.3. This reflects a small metadata update to the page's revision log rather than substantive changes to the study record.SummaryDifference0.1%

- Check41 days agoChange DetectedA new revision entry v3.5.3 has been added to the record history, and the previous v3.5.2 entry has been removed. This updates the page’s release notes in the history log.SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision entry (v3.5.2) was added to the history. The previous revision entry (v3.5.0) was removed.SummaryDifference0.1%

- Check84 days agoChange DetectedThe record history now includes Revision v3.5.0 and omits Revision v3.4.3.SummaryDifference0.1%

- Check91 days agoChange DetectedThe record history now includes a new revision entry v3.4.3 and removes v3.4.2 from the history.SummaryDifference0.1%

Stay in the know with updates to Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page.